Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.


Journal

Journal of hepatology
ISSN: 1600-0641
Titre abrégé: J Hepatol
Pays: Netherlands
ID NLM: 8503886

Informations de publication

Date de publication:
01 2019
Historique:
received: 14 05 2018
revised: 24 08 2018
accepted: 04 09 2018
pubmed: 24 9 2018
medline: 22 4 2020
entrez: 24 9 2018
Statut: ppublish

Résumé

Genetic hemochromatosis is mainly related to the homozygous p.Cys282Tyr (C282Y) mutation in the HFE gene, which causes hepcidin deficiency. Its low penetrance suggests the involvement of cofactors that modulate its expression. We aimed to describe the evolution of disease presentation and of non-genetic factors liable to impact hepcidin production in the long term. Clinical symptoms, markers of iron load, and risk factors according to the year of diagnosis were recorded over 30 years in a cohort of adult C282Y homozygotes. A total of 2,050 patients (1,460 probands [804 males and 656 females] and 542 relatives [244 males and 346 females]) were studied. Over time: (i) the proband-to-relative ratio remained roughly stable; (ii) the gender ratio tended towards equilibrium among probands; (iii) age at diagnosis did not change among males and increased among females; (iv) the frequency of diabetes and hepatic fibrosis steadily decreased while that of chronic fatigue and distal joint symptoms remained stable; (v) transferrin saturation, serum ferritin and the amount of iron removed decreased; and (vi) the prevalence of excessive alcohol consumption decreased while that of patients who were overweight increased. Tobacco smoking was associated with increased transferrin saturation. Genetic testing did not alter the age at diagnosis, which contrasts with the dramatic decrease in iron load in both genders. Tobacco smoking could be involved in the extent of iron loading. Besides HFE testing, which enables the diagnosis of minor forms of the disease, the reduction of alcohol consumption and the increased frequency of overweight patients may have played a role in the decreased long-term iron load, as these factors are likely to improve hepcidin production. Genetic hemochromatosis is an inherited disorder that leads to progressive iron overload in the body. It results in chronic fatigue and in potential liver (cirrhosis), pancreas (diabetes) and joint (arthritis) damage in adulthood. The present study showed that tobacco smoking may aggravate iron loading, but that hemochromatosis has become less and less severe over the last 30 years despite patients being older at diagnosis, likely because of the protective effects of lower alcohol consumption and of increased weight in the French population.

Sections du résumé

BACKGROUND & AIMS
Genetic hemochromatosis is mainly related to the homozygous p.Cys282Tyr (C282Y) mutation in the HFE gene, which causes hepcidin deficiency. Its low penetrance suggests the involvement of cofactors that modulate its expression. We aimed to describe the evolution of disease presentation and of non-genetic factors liable to impact hepcidin production in the long term.
METHODS
Clinical symptoms, markers of iron load, and risk factors according to the year of diagnosis were recorded over 30 years in a cohort of adult C282Y homozygotes. A total of 2,050 patients (1,460 probands [804 males and 656 females] and 542 relatives [244 males and 346 females]) were studied.
RESULTS
Over time: (i) the proband-to-relative ratio remained roughly stable; (ii) the gender ratio tended towards equilibrium among probands; (iii) age at diagnosis did not change among males and increased among females; (iv) the frequency of diabetes and hepatic fibrosis steadily decreased while that of chronic fatigue and distal joint symptoms remained stable; (v) transferrin saturation, serum ferritin and the amount of iron removed decreased; and (vi) the prevalence of excessive alcohol consumption decreased while that of patients who were overweight increased. Tobacco smoking was associated with increased transferrin saturation.
CONCLUSION
Genetic testing did not alter the age at diagnosis, which contrasts with the dramatic decrease in iron load in both genders. Tobacco smoking could be involved in the extent of iron loading. Besides HFE testing, which enables the diagnosis of minor forms of the disease, the reduction of alcohol consumption and the increased frequency of overweight patients may have played a role in the decreased long-term iron load, as these factors are likely to improve hepcidin production.
LAY SUMMARY
Genetic hemochromatosis is an inherited disorder that leads to progressive iron overload in the body. It results in chronic fatigue and in potential liver (cirrhosis), pancreas (diabetes) and joint (arthritis) damage in adulthood. The present study showed that tobacco smoking may aggravate iron loading, but that hemochromatosis has become less and less severe over the last 30 years despite patients being older at diagnosis, likely because of the protective effects of lower alcohol consumption and of increased weight in the French population.

Identifiants

pubmed: 30244162
pii: S0168-8278(18)32383-3
doi: 10.1016/j.jhep.2018.09.009
pii:
doi:

Substances chimiques

HFE protein, human 0
Hemochromatosis Protein 0
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-125

Informations de copyright

Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Auteurs

Yves Deugnier (Y)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France; CHU Rennes, National Reference Centre of Hemochromatosis and Other Iron-related Disorders, Pontchaillou Hospital, F-35033 Rennes, France; University Rennes 1, Faculty of Medicine, F-35340 Rennes, France; INSERM, CIC 1414, Pontchaillou Hospital, F-35033 Rennes, France. Electronic address: yves.deugnier@univ-rennes1.fr.

Jeff Morcet (J)

INSERM, CIC 1414, Pontchaillou Hospital, F-35033 Rennes, France.

Fabrice Lainé (F)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France; INSERM, CIC 1414, Pontchaillou Hospital, F-35033 Rennes, France.

Houda Hamdi-Roze (H)

CHU Rennes, Laboratory of Molecular Genetics, Pontchaillou Hospital, F-35033 Rennes, France.

Anne-Sophie Bollard (AS)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France.

Dominique Guyader (D)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France; University Rennes 1, Faculty of Medicine, F-35340 Rennes, France.

Romain Moirand (R)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France; University Rennes 1, Faculty of Medicine, F-35340 Rennes, France.

Edouard Bardou-Jacquet (E)

CHU Rennes, Liver Unit, Pontchaillou Hospital, F-35033 Rennes, France; CHU Rennes, National Reference Centre of Hemochromatosis and Other Iron-related Disorders, Pontchaillou Hospital, F-35033 Rennes, France; University Rennes 1, Faculty of Medicine, F-35340 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH